Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment

NCT05328167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Perflutren Protein-Type A Microspheres
PROCEDURE: Contrast-Enhanced Ultrasound

Sponsor

Thomas Jefferson University

Collaborators

[object Object]